Data / Form D filings / Oncocyte Corp
Oncocyte Corp: Form D filings
Oncocyte Corp, a biotechnology company in Irvine, CA, filed 9 Form D notices with the SEC between 2015 and 2025. The latest, on February 24, 2025, reports $21.7 million sold of a $21.7 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 15 CUSHING, Irvine, CA, 92618
- Phone
- (949) 409-7600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1642380
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | New notice | $21,743,597 | $21,743,597 | 12 | Feb 10, 2025 | sec.gov | |
| Oct 8, 2024 | New notice | $10,204,262 | $10,204,262 | 16 | Oct 2, 2024 | sec.gov | |
| Apr 25, 2024 | New notice | $15,807,692 | $15,807,692 | 21 | Apr 11, 2024 | sec.gov | |
| Apr 29, 2021 | New notice | $17,500,000 | $3,006,577 | $14,493,423 | 75 | Apr 15, 2021 | sec.gov |
| Mar 8, 2021 | New notice | $5,000,000 | $5,000,000 | 7 | Feb 24, 2021 | sec.gov | |
| Feb 11, 2020 | New notice | $11,000,000 | $5,000,000 | $6,000,000 | 29 | Jan 31, 2020 | sec.gov |
| Sep 9, 2016 | New notice | $10,549,997 | $10,549,997 | 9 | Aug 29, 2016 | sec.gov | |
| Oct 15, 2015 | New notice | $11,350,738 | $8,349,439 | $3,001,299 | 1 | Sep 29, 2015 | sec.gov |
| May 14, 2015 | New notice | $3,300,000 | $3,300,000 | 2 | May 8, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Louis Silverman | Director | |
| Andrew Last | Director | |
| Joshua Riggs | Executive Officer, Director | |
| Andrea James | Executive Officer | |
| James Liu | Executive Officer | |
| Andrew Arno | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 24, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Oncocyte Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.